HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive value of chart-based frailty evaluation for lung transplant candidates.

Abstract
Frailty, defined as a state of decreased physiologic reserve, has been correlated with poorer outcomes after hospitalization or surgery. Studies in lung transplant patients have associated frailty with an increased risk of post-transplant mortality; however, a unified approach is lacking. The identification of frail patients can help clinicians pre-emptively target modifiable risk factors and may facilitate risk stratification. The Frailty Risk Score (FRS) is a chart review-based approach based on eight symptoms and four laboratory biomarkers. We applied this method in a retrospective study to investigate its utility in predicting post-transplant lung outcomes. Eighty-four lung transplant recipients were evaluated, including 51 older (≥ 60) and 33 younger (< 60) patients. Median FRS score was 3.9, with 63 categorized as frail (75%) and 21 as non-frail (25%), using a previously published cut-off of ≥3 to define frailty. A high FRS was associated with readmission in the first year after transplantation and with the number of readmissions. There was also an association between FRS score and death (p = .047). FRS may be a viable tool in the assessment of lung transplant candidates. Frail patients may benefit from earlier referral and targeted therapy prior to transplant, as well as close post-transplant follow-up.
AuthorsSerina Gee, Yoon Lee, Aloukika Shah, Ehsan Izadmehr, John Belperio, Yusaku Shino, Sam Weigt, Deena Goldwater, Joanna Schaenman
JournalClinical transplantation (Clin Transplant) Vol. 36 Issue 1 Pg. e14461 (01 2022) ISSN: 1399-0012 [Electronic] Denmark
PMID34486175 (Publication Type: Journal Article)
Copyright© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Topics
  • Frailty (diagnosis)
  • Humans
  • Lung Transplantation
  • Retrospective Studies
  • Risk Factors
  • Transplant Recipients

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: